The JAK inhibitor tofacitinib ameliorates immune-mediated liver injury in mice

Wang, H; Feng, XX; Han, P; Lei, Y; Xia, YJ; Tian, DA; Yan, W

Tian, DA; Yan, W (reprint author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastroenterol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.

MOLECULAR MEDICINE REPORTS, 2019; 20 (6): 4883

Abstract

The prevalence of immune-mediated liver diseases such as autoimmune liver disease or viral hepatitis has increased in recent years, and the side effec......

Full Text Link